These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 37090048)

  • 21. Axonal Guillain-Barré syndrome: relation to anti-ganglioside antibodies and Campylobacter jejuni infection in Japan.
    Ogawara K; Kuwabara S; Mori M; Hattori T; Koga M; Yuki N
    Ann Neurol; 2000 Oct; 48(4):624-31. PubMed ID: 11026446
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of immunoblotting and ELISA for detection of anti-ganglioside antibodies in children with Guillain-Barre syndrome.
    Bonyadi MR; Barzegar M; Badalzadeh R; Hashemilar M
    Iran J Immunol; 2010 Jun; 7(2):117-23. PubMed ID: 20574125
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibodies to GT1a ganglioside in patients with Guillain-Barré syndrome.
    Ilyas AA; Cook SD; Mithen FA; Taki T; Kasama T; Handa S; Hamasaki H; Singhal BS; Li SC; Li YT
    J Neuroimmunol; 1998 Mar; 82(2):160-7. PubMed ID: 9585812
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gangliosides and Autoimmune Peripheral Nerve Diseases.
    Goodfellow JA; Willison HJ
    Prog Mol Biol Transl Sci; 2018; 156():355-382. PubMed ID: 29747820
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibodies against gangliosides and ganglioside complexes in Guillain-Barré syndrome: new aspects of research.
    Kusunoki S; Kaida K; Ueda M
    Biochim Biophys Acta; 2008 Mar; 1780(3):441-4. PubMed ID: 17976386
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Autoantibodies in Guillain-Barré Syndrome].
    Uchibori A; Chiba A
    Brain Nerve; 2015 Nov; 67(11):1347-57. PubMed ID: 26560950
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patterns and serial changes in electrodiagnostic abnormalities of axonal Guillain-Barré syndrome.
    Hiraga A; Kuwabara S; Ogawara K; Misawa S; Kanesaka T; Koga M; Yuki N; Hattori T; Mori M
    Neurology; 2005 Mar; 64(5):856-60. PubMed ID: 15753422
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical features of neuropathies in a group of patients associated with anti-GalNAc-GD1a antibody].
    Tatsumoto M; Odaka M; Koga M; Hirata K; Yuki N
    Rinsho Shinkeigaku; 2004 Aug; 44(8):508-12. PubMed ID: 15471085
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiganglioside antibodies are associated with axonal Guillain-Barré syndrome: a Japanese-Italian collaborative study.
    Sekiguchi Y; Uncini A; Yuki N; Misawa S; Notturno F; Nasu S; Kanai K; Noto Y; Fujimaki Y; Shibuya K; Ohmori S; Sato Y; Kuwabara S
    J Neurol Neurosurg Psychiatry; 2012 Jan; 83(1):23-8. PubMed ID: 22010183
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Guillain-Barré and Fisher syndromes: update on the pathophysiological role of antiganglioside antibodies].
    Kaida K
    Rinsho Shinkeigaku; 2012; 52(11):914-6. PubMed ID: 23196466
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Antiganglioside antibodies: when, which and for what].
    Gallardo E; Rojas-García R; Belvís R; Serrano-Munuera C; Ortiz E; Ortiz N; Grau J; Illa I
    Neurologia; 2001; 16(7):293-7. PubMed ID: 11485721
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical relevance of serum antibodies to GD1b in immune-mediated neuropathies.
    Taams NE; Notermans NC; Fokkink WR; Tio-Gillen AP; Huizinga R; Schreurs MWJ; Jacobs BC
    J Peripher Nerv Syst; 2018 Dec; 23(4):227-234. PubMed ID: 30101437
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dysfunction of nodes of Ranvier: a mechanism for anti-ganglioside antibody-mediated neuropathies.
    Susuki K; Yuki N; Schafer DP; Hirata K; Zhang G; Funakoshi K; Rasband MN
    Exp Neurol; 2012 Jan; 233(1):534-42. PubMed ID: 22178332
    [TBL] [Abstract][Full Text] [Related]  

  • 34. GD1b-specific antibody induces ataxia in Guillain-Barre syndrome.
    Kaida K; Kamakura K; Ogawa G; Ueda M; Motoyoshi K; Arita M; Kusunoki S
    Neurology; 2008 Jul; 71(3):196-201. PubMed ID: 18625966
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IgG antiganglioside antibodies in Guillain-Barré syndrome with bulbar palsy.
    Yoshino H; Harukawa H; Asano A
    J Neuroimmunol; 2000 Jun; 105(2):195-201. PubMed ID: 10742563
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Guillain-Barré syndrome.
    Hughes RA; Cornblath DR
    Lancet; 2005 Nov; 366(9497):1653-66. PubMed ID: 16271648
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnostic Utility of Auto Antibodies in Inflammatory Nerve Disorders.
    Emilien D; Hugh W
    J Neuromuscul Dis; 2015 Jun; 2(2):107-112. PubMed ID: 27858733
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of Antecedent Infections on the Antibodies against Gangliosides and Ganglioside Complexes in Guillain-Barré Syndrome: A Correlative Study.
    Dutta D; Debnath M; Seshagiri DV; Nair BVS; Das SK; Wahatule R; Sinha S; Ravi V; Taly AB; Nagappa M
    Ann Indian Acad Neurol; 2022; 25(3):401-406. PubMed ID: 35936588
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Guillain-barré syndrome.
    Kuwabara S
    Curr Neurol Neurosci Rep; 2007 Jan; 7(1):57-62. PubMed ID: 17217855
    [TBL] [Abstract][Full Text] [Related]  

  • 40. GalNAc-GD1a in human peripheral nerve: target sites of anti-ganglioside antibody.
    Kaida K; Kusunoki S; Kamakura K; Motoyoshi K; Kanazawa I
    Neurology; 2003 Aug; 61(4):465-70. PubMed ID: 12939418
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.